Nesiritide: all 55 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Nesiritide in HypertensionRecruitingNCT02608996Phase 1/2
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1TerminatedNCT03738878Phase 4Results posted
- Nesiritide and Renal Function After the Total Artificial HeartTerminatedNCT01836809Phase 4Results posted
- Tadalafil and Nesiritide as Therapy in Pre-clinical Heart FailureCompletedNCT01544998Phase 1/2Results posted
- Nesiritide in Resistant HypertensionTerminatedNCT01514357Phase 1/2Results posted
- Does Nesiritide Provide Renal ProtectionCompletedNCT01440881Phase 2Results posted
- Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) StudyCompletedNCT01132846Phase 2Results posted
- Assessment of Biomarkers and Cardiorenal Syndrome in Acute Decompensated Heart Failure With Vasodilator TherapyCompletedNCT00842023Phase 4Results posted
- Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial InfarctionCompletedNCT00573144Phase 2Results posted
- Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan SurgeryTerminatedNCT00543309Phase 2Results posted
- An Exploratory Study of Nesiritide in Participants With Acute Heart FailureCompletedNCT00490724Phase 2Results posted
- A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart FailureCompletedNCT00475852Phase 3Results posted
- Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping FunctionCompletedNCT00405639Phase 1/2Results posted
- Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.CompletedNCT00405548Phase 1/2Results posted
- Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle DysfunctionCompletedNCT00387621Phase 1/2Results posted
- Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney FailureTerminatedNCT00348556Phase 1/2Results posted
- Nesiritide Use Following Cardiac Surgery in InfantsTerminatedNCT00281671Phase 1/2Results posted
- Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart FailureCompletedNCT00252187Phase 1/2Results posted
- Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in ChildrenStatus unknownNCT03207295Not applicable
- Natriuretic Peptides and Metabolic Risk in ObesityWithdrawnNCT02642523Early Phase 1
- Septic cArdiac Deficiency and MenIngococcal seveRe SepsisCompletedNCT02041663Not applicable
- BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese SubjectsCompletedNCT01977859Phase 1
- Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived PeptidesCompletedNCT01375153Not applicable
- Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal DysfunctionCompletedNCT00972569Phase 1/2
- B-type Natriuretic Peptide (BNP) in Human HypertensionTerminatedNCT00953472Phase 1
- Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal DysfunctionTerminatedNCT00818701Phase 1
- An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart FailureCompletedNCT00813202Phase 3
- Nesiritide - Dilated CardiomyopathyCompletedNCT00709163Not applicable
- Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPACompletedNCT00653042Phase 2
- Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSSCompletedNCT00652652Phase 4
- Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways DiseaseTerminatedNCT00562692Phase 3
- Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency DepartmentCompletedNCT00559338Phase 4
- An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)WithdrawnNCT00530361Phase 3
- Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EFWithdrawnNCT00505791Phase 4
- BNP Therapy Observation Unit Outcomes STudy (BOOST)TerminatedNCT00453453Phase 4
- Study of Nesiritide in Diastolic Heart Failure.CompletedNCT00309868Phase 1/2
- A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at RestCompletedNCT00288730Phase 3
- A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood VesselsCompletedNCT00271557Phase 3
- Renal Effects of Intrarenal NesiritideTerminatedNCT00270829Phase 4
- A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart FailureCompletedNCT00270400Phase 3
- A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care TherapyCompletedNCT00270387Phase 3
- A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.CompletedNCT00270374Phase 3
- FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.CompletedNCT00270361Phase 3
- Effect of BNP (Brain Natriuretic Peptides) on Endothelial Dysfunction Induced by Coronary AngioplastyStatus unknownNCT00262574Phase 4
- Natrecor for Pulmonary Hypertension in Lung TransplantsCompletedNCT00205426Phase 4
- Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial RelaxationCompletedNCT00204984Not applicable
- Catheterization Laboratory Study: Acute Responses in Diastolic Heart FailureCompletedNCT00204945Not applicable
- Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart FailureCompletedNCT00170183Phase 3
- Effects of Nesiritide in Pediatric Patients With Heart FailureWithdrawnNCT00166010Not applicable
- Nesiritide in Chronic Heart FailureTerminatedNCT00145873Phase 2
- Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal DysfunctionCompletedNCT00119691Phase 2
- The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal FailureStatus unknownNCT00110201Phase 3
- A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart FailureCompletedNCT00091520Phase 2
- Use of Nesiritide in the Management of Acute Diastolic Heart FailureTerminatedNCT00083772Phase 4
- Natrecor in Pulmonary HypertensionTerminatedNCT00075179Phase 4